E
Erik Ingelsson
Researcher at Stanford University
Publications - 546
Citations - 99427
Erik Ingelsson is an academic researcher from Stanford University. The author has contributed to research in topics: Genome-wide association study & Population. The author has an hindex of 124, co-authored 538 publications receiving 85407 citations. Previous affiliations of Erik Ingelsson include Karolinska Institutet & Cardiovascular Institute of the South.
Papers
More filters
Journal ArticleDOI
Persistent organic pollutants and liver dysfunction biomarkers in a population-based human sample of men and women.
TL;DR: Various POPs including PCBs, OCDD and pesticides were associated with the liver dysfunction biomarkers bilirubin, ALT and ALP, suggesting adverse effects on liver function from these environmental pollutants.
Journal ArticleDOI
Clinical depression, antidepressant use and risk of future cardiovascular disease
Iffat Rahman,Keith Humphreys,Anna M. Bennet,Erik Ingelsson,Nancy L. Pedersen,Patrik Karl Erik Magnusson +5 more
TL;DR: Depression and antidepressant use were both associated with CVD development and the hazard rate for CVD outcomes was highest among depressed patients who had not used antidepressants, supporting that depression is a possible risk factor for development of CVD.
Journal ArticleDOI
Clinical Correlates of Circulating Visfatin Levels in a Community-Based Sample
Erik Ingelsson,Martin G. Larson,Caroline S. Fox,Caroline S. Fox,Xiaoyan Yin,Thomas J. Wang,Izabella Lipinska,Karla M. Pou,Udo Hoffmann,Emelia J. Benjamin,John F. Keaney,Ramachandran S. Vasan,Ramachandran S. Vasan +12 more
TL;DR: The Framingham Third Generation Cohort (FGC) cohort as discussed by the authors was used to investigate the relationship of visfatin concentrations with other cardiovascular risk factors in the general population, including obesity, diabetes, and visceral adiposity.
Journal ArticleDOI
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
Christoph Nowak,Axel C. Carlsson,Axel C. Carlsson,Carl Johan Östgren,Fredrik H. Nystrom,Moudud Alam,Tobias Feldreich,Johan Sundström,Juan Jesus Carrero,Jerzy Leppert,Pär Hedberg,Egil Henriksen,Antonio C. Cordeiro,Vilmantas Giedraitis,Lars Lind,Erik Ingelsson,Tove Fall,Johan Ärnlöv,Johan Ärnlöv +18 more
TL;DR: Eight protein biomarkers, four of which are novel, for risk of MACE in community residents with type 2 diabetes are identified and improved risk prediction is found by combining multiplex proteomics with an established risk model.
Journal ArticleDOI
Contemporary trends in dyslipidemia in the Framingham Heart Study.
Erik Ingelsson,Joseph M. Massaro,Patrice Sutherland,Paul F. Jacques,Daniel Levy,Ralph B. D'Agostino,Ramachandran S. Vasan,Sander J. Robins +7 more
TL;DR: During a 10-year period of recent examinations in the Framingham Heart Study there was a decrease in dyslipidemia with an increase in HDL-C levels and a decreases in levels of TG despite an overall increase in BMI.